IMS Health

inVentiv to acquire Kforce

Monday, March 19, 2012 12:39 PM

Burlington, Mass.-based inVentiv Health, which offers clinical, commercial and consulting services to the healthcare industry, has signed a definitive agreement to acquire Kforce Clinical Research (KCR), a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies, from Kforce Inc. for $50 million in cash.

More... »

inVentiv Health to acquire SDI businesses from IMS Health

Friday, January 20, 2012 02:53 PM

Burlington, Mass.-based inVentiv Health will acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.  Financial terms were not disclosed.

More... »

AstraZeneca, IMS Health team up to use real-world evidence

Wednesday, January 11, 2012 03:40 PM

AstraZeneca has entered into a three-year collaboration agreement with IMS Health, a leading provider of healthcare information, services and technology, to further the use of real-world evidence based on observational and retrospective studies.

More... »

Actavis expands to Latin America

Friday, October 7, 2011 11:49 AM

Actavis Group CEO Claudio Albrecht has reported a major sales expansion into Latin America, among the world's fastest-growing markets for generic drugs.

More... »

PPD names CEO, puts acquisition rumors in question

Monday, September 26, 2011 08:02 AM

PPD has named a new CEO, a move that strikes some in the industry as a little strange in the face of rumors that the publicly traded CRO is close to selling itself to a private equity firm.

More... »

PPD names Hill CEO

Tuesday, September 20, 2011 10:14 AM

CRO PPD, which has been the subject of takeover speculation since July, has named Raymond Hill its new chief executive officer, filling a position that was vacant since mid-May, according to a PharmaTimes report.

More... »

IMS Health forecast: Global pharmaceutical market poised for growth in 2011 to $880 billion

Monday, October 25, 2010 09:02 AM

Robust pharmaceutical spending in 17 emerging countries led by China, and those governments making more treatment options available to their citizens, will offset patent losses and slow growth in the United States pharmaceutical market, according to a forecast by IMS Health.

More... »